MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LH made $3,537,600K in revenue. $277,800K in net income. Net profit margin of 7.85%.

Income Overview

Revenue
$3,537,600K
Net Income
$277,800K
Net Profit Margin
7.85%
EPS
$3.35
Unit: Thousand (K) dollars
Revenue Breakdown
    • Diagnostics-Operating Segments
    • Biopharma Laboratory Services-Op...

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
3,537,600 3,515,800 3,563,500 3,527,300
Cost of revenues
2,523,800 2,522,600 2,538,400 2,481,100
Gross profit
1,013,800 993,200 1,025,100 1,046,200
Selling, general, and administrative expenses
551,000 538,600 552,400 579,300
Amortization of intangibles and other assets
75,600 72,600 69,500 68,300
Asset impairment charges
-3,600 700 0
Restructuring and other charges
6,400 110,800 5,900 4,100
Operating income
380,800 267,600 396,600 394,500
Interest expense
55,100 55,000 56,000 57,100
Investment income
12,200 3,500 3,500 1,700
Equity method loss, net
-5,100 -6,100 -5,200 -1,700
Other, net
-13,100 -19,400 -1,900 -32,700
Earnings from operations before income taxes
319,700 190,600 337,000 304,700
Provision for income taxes
41,700 25,700 75,500 66,400
Earnings from continuing operations
-164,900* --
Earnings from discontinued operations, net of tax
-0* --
Net earnings
278,000 164,900 261,500 238,300
Less net earnings attributable to the noncontrolling interest
200 200 400 400
Net earnings attributable to labcorp holdings inc
277,800 164,700 261,100 237,900
Basic EPS
3.37 1.992 3.14 2.85
Diluted EPS
3.35 1.977 3.12 2.84
Basic Average Shares
82,300,000 82,700,000 83,100,000 83,400,000
Diluted Average Shares
82,900,000 83,300,000 83,700,000 83,900,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Diagnostics-Operating Segments$2,762,100K (5.04%↑ Y/Y)Biopharma LaboratoryServices-Operating Segments$780,600K (8.22%↑ Y/Y)Revenues$3,537,600K (5.75%↑ Y/Y)Intersegment Elimination-$5,100K (12.07%↑ Y/Y)Gross profit$1,013,800K (6.94%↑ Y/Y)Cost of revenues$2,523,800K (5.29%↑ Y/Y)Operating income$380,800K (16.81%↑ Y/Y)Investment income$12,200K (87.69%↑ Y/Y)Selling, general, andadministrative expenses$551,000K (0.92%↑ Y/Y)Amortization of intangiblesand other assets$75,600K (8.62%↑ Y/Y)Restructuring and othercharges$6,400K (0.00%↑ Y/Y)Earnings from operationsbefore income taxes$319,700K (16.17%↑ Y/Y)Interest expense$55,100K (-1.61%↓ Y/Y)Other, net-$13,100K (-1210.00%↓ Y/Y)Equity method loss, net-$5,100K (-1600.00%↓ Y/Y)Net earnings$278,000K (30.52%↑ Y/Y)Provision for income taxes$41,700K (-32.96%↓ Y/Y)Net earningsattributable to labcorp...$277,800K (30.55%↑ Y/Y)Less net earningsattributable to the...$200K (0.00%↑ Y/Y)

Labcorp_Logo-svg

LABCORP HOLDINGS INC. (LH)

Labcorp_Logo-svg

LABCORP HOLDINGS INC. (LH)